A randomized study of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in elderly patients with acute lymphoblastic leukemia: the GRAALL-SA1 study
Mathilde Hunault; T. Leguay; Xavier Thomas; O. Legrand; Françoise Huguet; Caroline Bonmati; Martine Escoffre‐Barbe; Laurence Legros · 2010 · Haematologica
WASTE classifies this as Negative / Null Result Report · AI classification, approximate
The study found no significant effect — useful as a negative control or null benchmark for your own design.
Abstract (excerpt)
BACKGROUND: The prognosis of acute lymphoblastic leukemia in the elderly is poor. The GRAALL-SA1 phase II, randomized trial compared the efficacy and toxicity of pegylated liposomal doxorubicin versus continuous-infusion doxorubicin in…
Excerpt shown for reference under fair use — read the full paper at the publisher.
About to run something similar?
Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.
Related failures
Fabrication of alginate–gelatin crosslinked hydrogel microcapsules and evaluation of the microstructure and physico-chemical properties
Negative / Null Result ReportOxygen Vacancy‐Induced Dielectric Polarization Prevails in the Electromagnetic Wave‐Absorbing Mechanism for Mn‐Based MOFs‐Derived Composites
Negative / Null Result ReportRole of the surface effect on the structural, electronic and mechanical properties of the carbide MXenes
Negative / Null Result ReportPhase behaviour and complex coacervation of aqueous polypeptide solutions
Negative / Null Result ReportNeedleless Melt‐Electrospinning of Polypropylene Nanofibres
Negative / Null Result ReportOn the Origin of Surface Traps in Colloidal II–VI Semiconductor Nanocrystals
WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.
Metadata source: OpenAlex · DOI 10.3324/haematol.2010.027862